2 Antepartum cardiotocography

Carl Vernon Smith, Richard H. Paul

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Antepartum cardiotocography remains a valuable adjunct in the management of the high-risk gravida. Twice weekly use of NST coupled with real-time ultrasound assessment of amniotic fluid volume appear reasonable approaches to testing. More controversial is the use of testing in all pregnancies. Clearly, if one could reduce the perinatal mortality to 1-2/1000, such universal application of testing could be justified. However, more pragmatic concerns, such as personnel and cost constraints have all but prohibited the adoption of this policy. Secondly, in an attempt to improve the predictive reliability of antenatal testing additional evaluation of patients demonstrating diminished AFV or variable decelerations should be considered. More frequent testing or consideration for delivery are reasonable management plans. Finally, the use of acoustic stimulation to reduce the frequency of persistently non-reactive NSTs offers considerable promise. Investigations in this and other techniques of surveillance are ongoing. The best single method remains to be discovered, but utilization of current techniques offers the obstetrician a reliable technique by which to assess fetal well-being.

Original languageEnglish (US)
Pages (from-to)17-28
Number of pages12
JournalBailliere's Clinical Obstetrics and Gynaecology
Volume1
Issue number1
DOIs
StatePublished - Jan 1 1987

Fingerprint

Cardiotocography
Acoustic Stimulation
Deceleration
Perinatal Mortality
Risk Management
Amniotic Fluid
Costs and Cost Analysis
Pregnancy
Haemophilus influenzae type b-polysaccharide vaccine-diphtheria toxoid conjugate

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

2 Antepartum cardiotocography. / Smith, Carl Vernon; Paul, Richard H.

In: Bailliere's Clinical Obstetrics and Gynaecology, Vol. 1, No. 1, 01.01.1987, p. 17-28.

Research output: Contribution to journalArticle

@article{c54dad8cbb384d199a6e0f94316b40ca,
title = "2 Antepartum cardiotocography",
abstract = "Antepartum cardiotocography remains a valuable adjunct in the management of the high-risk gravida. Twice weekly use of NST coupled with real-time ultrasound assessment of amniotic fluid volume appear reasonable approaches to testing. More controversial is the use of testing in all pregnancies. Clearly, if one could reduce the perinatal mortality to 1-2/1000, such universal application of testing could be justified. However, more pragmatic concerns, such as personnel and cost constraints have all but prohibited the adoption of this policy. Secondly, in an attempt to improve the predictive reliability of antenatal testing additional evaluation of patients demonstrating diminished AFV or variable decelerations should be considered. More frequent testing or consideration for delivery are reasonable management plans. Finally, the use of acoustic stimulation to reduce the frequency of persistently non-reactive NSTs offers considerable promise. Investigations in this and other techniques of surveillance are ongoing. The best single method remains to be discovered, but utilization of current techniques offers the obstetrician a reliable technique by which to assess fetal well-being.",
author = "Smith, {Carl Vernon} and Paul, {Richard H.}",
year = "1987",
month = "1",
day = "1",
doi = "10.1016/S0950-3552(87)80021-4",
language = "English (US)",
volume = "1",
pages = "17--28",
journal = "Bailliere's Clinical Obstetrics and Gynaecology",
issn = "0950-3552",
publisher = "Bailliere Tindall Ltd",
number = "1",

}

TY - JOUR

T1 - 2 Antepartum cardiotocography

AU - Smith, Carl Vernon

AU - Paul, Richard H.

PY - 1987/1/1

Y1 - 1987/1/1

N2 - Antepartum cardiotocography remains a valuable adjunct in the management of the high-risk gravida. Twice weekly use of NST coupled with real-time ultrasound assessment of amniotic fluid volume appear reasonable approaches to testing. More controversial is the use of testing in all pregnancies. Clearly, if one could reduce the perinatal mortality to 1-2/1000, such universal application of testing could be justified. However, more pragmatic concerns, such as personnel and cost constraints have all but prohibited the adoption of this policy. Secondly, in an attempt to improve the predictive reliability of antenatal testing additional evaluation of patients demonstrating diminished AFV or variable decelerations should be considered. More frequent testing or consideration for delivery are reasonable management plans. Finally, the use of acoustic stimulation to reduce the frequency of persistently non-reactive NSTs offers considerable promise. Investigations in this and other techniques of surveillance are ongoing. The best single method remains to be discovered, but utilization of current techniques offers the obstetrician a reliable technique by which to assess fetal well-being.

AB - Antepartum cardiotocography remains a valuable adjunct in the management of the high-risk gravida. Twice weekly use of NST coupled with real-time ultrasound assessment of amniotic fluid volume appear reasonable approaches to testing. More controversial is the use of testing in all pregnancies. Clearly, if one could reduce the perinatal mortality to 1-2/1000, such universal application of testing could be justified. However, more pragmatic concerns, such as personnel and cost constraints have all but prohibited the adoption of this policy. Secondly, in an attempt to improve the predictive reliability of antenatal testing additional evaluation of patients demonstrating diminished AFV or variable decelerations should be considered. More frequent testing or consideration for delivery are reasonable management plans. Finally, the use of acoustic stimulation to reduce the frequency of persistently non-reactive NSTs offers considerable promise. Investigations in this and other techniques of surveillance are ongoing. The best single method remains to be discovered, but utilization of current techniques offers the obstetrician a reliable technique by which to assess fetal well-being.

UR - http://www.scopus.com/inward/record.url?scp=0023639353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023639353&partnerID=8YFLogxK

U2 - 10.1016/S0950-3552(87)80021-4

DO - 10.1016/S0950-3552(87)80021-4

M3 - Article

VL - 1

SP - 17

EP - 28

JO - Bailliere's Clinical Obstetrics and Gynaecology

JF - Bailliere's Clinical Obstetrics and Gynaecology

SN - 0950-3552

IS - 1

ER -